HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.

AbstractBACKGROUND:
Patients diagnosed with melanoma brain metastases have few treatment options and poor prognosis, and improved treatment strategies for these patients require detailed understanding of the underlying pathobiology. In this investigation we studied the vascularity and invasiveness of artificial brain metastases established from four human melanoma cell lines.
METHODS:
A-07, D-12, R-18, and U-25 cells transfected with GFP were injected intracerebrally and intra-arterially in nude mice. Moribund mice were killed and autopsied, and the brain was evaluated by fluorescence imaging or by histological examination. Expression and secretion of factors involved in angiogenesis and invasion were assessed by quantitative PCR, ELISA, and immunohistochemistry.
RESULTS:
The melanoma cells grew preferentially in the meninges and ventricles after intracerebral and intra-arterial injection. Intertumor heterogeneity in the aggressiveness of meningeal tumors reflected differences in angiogenic activity and expression of vascular endothelial growth factor A (VEGF-A) and interleukin 8 (IL-8). In contrast, growth and invasion of the brain parenchyma relied primarily on vascular co-option. The cell lines showed different patterns of invasion from meninges to the scull and from meninges to the brain parenchyma, and these differences were associated with differences in expression of the matrix metalloproteinases MMP-2 and MMP-9. Furthermore, the melanoma cells produced multiple brain lesions after intracerebral implantation by using the meningeal linings of the brain as transport routes.
CONCLUSIONS:
The melanoma cell lines showed different growth patterns in the brain, and these differences were associated with differences in expression of the angiogenic factors VEGF-A and IL-8 and the matrix metalloproteinases MMP-2 and MMP-9.
AuthorsTrude G Simonsen, Jon-Vidar Gaustad, Einar K Rofstad
JournalJournal of experimental & clinical cancer research : CR (J Exp Clin Cancer Res) Vol. 34 Pg. 150 (Dec 15 2015) ISSN: 1756-9966 [Electronic] England
PMID26667022 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-8
  • Vascular Endothelial Growth Factor A
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
Topics
  • Animals
  • Brain Neoplasms (diagnostic imaging, genetics, pathology, secondary)
  • Gene Expression Regulation, Neoplastic
  • Genetic Heterogeneity
  • Humans
  • Interleukin-8 (biosynthesis, genetics)
  • Matrix Metalloproteinase 2 (biosynthesis, genetics)
  • Matrix Metalloproteinase 9 (biosynthesis, genetics)
  • Melanoma (diagnostic imaging, genetics, pathology)
  • Mice
  • Neoplasm Invasiveness (genetics, pathology)
  • Neoplasm Metastasis
  • Neovascularization, Pathologic (diagnostic imaging, genetics, pathology)
  • Optical Imaging
  • Radiography
  • Vascular Endothelial Growth Factor A (biosynthesis, genetics)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: